{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:41:17Z","timestamp":1789072877891,"version":"build-2803163510"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Nitric Oxide (NO) signaling pathway plays a vital role in various physiological and pathophysiological processes including vasodilation, neurogenesis, inflammation, translation and protein regulation. NO signaling pathway is associated with various diseases such as cardiovascular diseases, vision impairment, hypertension and Alzheimer\u2019s disease. Human Endothelial Nitric Oxide Synthase (eNOS) bound with calcium regulatory protein (calmodulin (CaM)) to produce NO which initiates cGMP pathway. The current study employs to screen the novel compounds against human eNOS independent of calcium regulatory protein (CaM). The current effort emphasized that the deficiency of CaM leads to dysfunction of cGMP signaling pathway. In this work, a hybrid approach of high-throughput virtual screening and comparative molecular docking studies followed by molecular dynamic simulation analyses were applied. The screening of top ranked two novel compounds against eNOS were reported that showed effective binding affinity, retrieved through the DrugBank and ZINC database libraries. Comparative molecular docking analyses revealed that Val-104, Phe-105, Gln-247, Arg-250, Ala-266, Trp-330, Tyr-331, Pro-334, Ala-335, Val-336, Tyr-357, Met-358, Thr-360, Glu-361, Ile-362, Arg-365, Asn-366, Asp-369, Arg-372, Trp-447 and Tyr-475 are potent residues for interactional studies. High-throughput virtual screening approach coupled with molecular dynamic simulation and drug likeness rules depicted that ZINC59677432 and DB00456 are potent compounds to target eNOS. In conclusion, the proposed compounds are potent against eNOS based on extensive <jats:italic>in silico<\/jats:italic> analyses. Overall, the findings of this study may be helpful to design therapeutic targets against eNOS.<\/jats:p>","DOI":"10.1371\/journal.pone.0284993","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:38:28Z","timestamp":1682530708000},"page":"e0284993","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction"],"prefix":"10.1371","volume":"18","author":[{"given":"Abbeha","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nasir","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidrah","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Saleem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Shahzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farhan","family":"Shafique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zureesha","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3901-5344","authenticated-orcid":true,"given":"Sheikh Arslan","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"pone.0284993.ref001","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2015.152","article-title":"Environmental factors in cardiovascular disease","volume":"12","author":"KE Cosselman","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"pone.0284993.ref002","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5603\/KP.a2018.0213","article-title":"Depressive symptoms and cardiovascular diseases in the adult Polish population. Results of the NATPOL2011 study","volume":"77","author":"J Piwonski","year":"2019","journal-title":"Kardiol Pol"},{"key":"pone.0284993.ref003","first-page":"e153","article-title":"Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association","volume":"145","author":"CW Tsao","year":"2022","journal-title":"Circulation"},{"key":"pone.0284993.ref004","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.jacc.2020.08.059","article-title":"Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia: JACC Focus Seminar","volume":"76","author":"G Giustino","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"pone.0284993.ref005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action","volume":"62","author":"SH Francis","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"pone.0284993.ref006","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics. Pharmacology &","volume":"122","author":"EJ Tsai","year":"2009","journal-title":"Therapeutics"},{"key":"pone.0284993.ref007","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/338078a0","article-title":"A Membrane Form of Guanylate-Cyclase Is an Atrial Natriuretic Peptide Receptor","volume":"338","author":"M Chinkers","year":"1989","journal-title":"Nature"},{"key":"pone.0284993.ref008","author":"L Agullo","year":"2007","journal-title":"General Scheme of the Pathway"},{"key":"pone.0284993.ref009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/niox.2001.0394","article-title":"Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases","volume":"6","author":"AJ Maxwell","year":"2002","journal-title":"Nitric Oxide"},{"key":"pone.0284993.ref010","doi-asserted-by":"crossref","first-page":"5925714","DOI":"10.1155\/2017\/5925714","article-title":"Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms","volume":"2017","author":"SA Sehgal","year":"2017","journal-title":"Biomed Res Int"},{"key":"pone.0284993.ref011","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fmolb.2020.00227","article-title":"Determine the Potential Epitope Based Peptide Vaccine Against Novel SARS-CoV-2 Targeting Structural Proteins Using Immunoinformatics Approaches","volume":"7","author":"M Waqas","year":"2020","journal-title":"Front Mol Biosci"},{"key":"pone.0284993.ref012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jtbi.2018.10.005","article-title":"Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein","volume":"459","author":"RA Tahir","year":"2018","journal-title":"J Theor Biol"},{"key":"pone.0284993.ref013","doi-asserted-by":"crossref","first-page":"e0228265","DOI":"10.1371\/journal.pone.0228265","article-title":"(2020) In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1.","volume":"15","author":"RA Tahir","journal-title":"PLoS One"},{"key":"pone.0284993.ref014","doi-asserted-by":"crossref","first-page":"1596834","DOI":"10.1155\/2021\/1596834","article-title":"Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening","volume":"2021","author":"M Waqas","year":"2021","journal-title":"BioMed Research International"},{"key":"pone.0284993.ref015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4682-10-3","article-title":"Structural, phylogenetic and docking studies of D-amino acid oxidase activator (DAOA), a candidate schizophrenia gene","volume":"10","author":"SA Sehgal","year":"2013","journal-title":"Theor Biol Med Model"},{"key":"pone.0284993.ref016","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2147\/DDDT.S101929","article-title":"Pharmacoinformatic and molecular docking studies reveal potential novel antidepressants against neurodegenerative disorders by targeting HSPB8","volume":"10","author":"SA Sehgal","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"pone.0284993.ref017","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2174\/1386207324666210217144306","article-title":"The Life Cycle and in silico Elucidation of Non-structural Replicating Proteins of HCV Through a Pharmacoinformatics Approach","volume":"25","author":"RA Tahir","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"key":"pone.0284993.ref018","doi-asserted-by":"crossref","first-page":"13263","DOI":"10.1002\/jcp.27999","article-title":"Pharmacoinformatics and molecular docking reveal potential drug candidates against Schizophrenia to target TAAR6","volume":"234","author":"RA Tahir","year":"2019","journal-title":"J Cell Physiol"},{"key":"pone.0284993.ref019","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.2174\/1568026619666191112104217","article-title":"Ligand-Based Pharmacophore Modeling and Virtual Screening to Discover Novel CYP1A1 Inhibitors","volume":"19","author":"RA Tahir","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"pone.0284993.ref020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1386207321666180213092018","article-title":"Pharmacoinformatics and Molecular Docking Studies Reveal Potential Novel Compounds Against Schizophrenia by Target SYN II","volume":"21","author":"RA Tahir","year":"2018","journal-title":"Comb Chem High Throughput Screen"},{"key":"pone.0284993.ref021","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12539-016-0145-z","article-title":"Comparative Modeling, Molecular Docking, and Revealing of Potential Binding Pockets of RASSF2; a Candidate Cancer Gene","volume":"9","author":"S Kanwal","year":"2017","journal-title":"Interdiscip Sci"},{"key":"pone.0284993.ref022","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00044-016-1752-2","article-title":"Pharmacoinformatics and molecular docking studies reveal potential novel Proline Dehydrogenase (PRODH) compounds for Schizophrenia inhibition","volume":"26","author":"SA Sehgal","year":"2017","journal-title":"Medicinal Chemistry Research"},{"key":"pone.0284993.ref023","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2147\/DDDT.S63096","article-title":"Pharmacoinformatics elucidation of potential drug targets against migraine to target ion channel protein KCNK18","volume":"8","author":"SA Sehgal","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"pone.0284993.ref024","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nchembio.115","article-title":"Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase","volume":"4","author":"ED Garcin","year":"2008","journal-title":"Nat Chem Biol"},{"key":"pone.0284993.ref025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0959-440X(96)80061-3","article-title":"Computational methods for biomolecular docking","volume":"6","author":"T Lengauer","year":"1996","journal-title":"Curr Opin Struct Biol"},{"key":"pone.0284993.ref026","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511730412","author":"KM Merz","year":"2010","journal-title":"Drug Design: Structure- and Ligand-Based Approaches"},{"key":"pone.0284993.ref027","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"H Yang","year":"2019","journal-title":"Bioinformatics"},{"key":"pone.0284993.ref028","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ci300367a","article-title":"admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties","volume":"52","author":"F Cheng","year":"2012","journal-title":"J Chem Inf Model"},{"key":"pone.0284993.ref029","article-title":"Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters: IEEE","author":"David E. Bowers KJaC","year":"2006"},{"key":"pone.0284993.ref030","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","volume":"20","author":"LG Ferreira","year":"2015","journal-title":"Molecules"},{"key":"pone.0284993.ref031","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.tibs.2019.06.004","article-title":"Bringing Molecular Dynamics Simulation Data into View","volume":"44","author":"PW Hildebrand","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"pone.0284993.ref032","article-title":"Identification of Lead Compounds against Scm (fms10) in Enterococcus faecium Using Computer Aided Drug Designing","volume":"11","author":"MA Rasheed","year":"2021","journal-title":"Life (Basel)"},{"key":"pone.0284993.ref033","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field","volume":"6","author":"D Shivakumar","year":"2010","journal-title":"Journal of Chemical Theory and Computation"},{"key":"pone.0284993.ref034","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"F Aktan","year":"2004","journal-title":"Life Sci"},{"key":"pone.0284993.ref035","doi-asserted-by":"crossref","first-page":"29769","DOI":"10.1074\/jbc.272.47.29769","article-title":"An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase","volume":"272","author":"JC Salerno","year":"1997","journal-title":"J Biol Chem"},{"key":"pone.0284993.ref036","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"WK Alderton","year":"2001","journal-title":"Biochem J"},{"key":"pone.0284993.ref037","doi-asserted-by":"crossref","first-page":"25062","DOI":"10.1016\/S0021-9258(17)31498-9","article-title":"Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity","volume":"269","author":"P Chen","year":"1994","journal-title":"The Journal of biological chemistry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:39:01Z","timestamp":1682530741000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0284993"}},"subtitle":[],"editor":[{"given":"Taye Beyene","family":"Demissie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0284993","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]}}}